Fake and second-rate antibiotics are a major global threat to the fight against infectious diseases. Offering respite, a team of researchers at Colorado State University headed by Professor Chuck Harry design a test to spot bogus or mediocre antibiotics. It uses paper and is easy and economical.
The National Cancer Institute team has discovered how bacteria in the gut affects anti-tumor immune responses in the liver, a connection that could be used to find new therapies for liver cancer.
Sepsis, a potentially life-threatening complication of infection, is currently treated with antibiotics which kill the infection-causing bacteria. But research out of the University of Pennsylvania spotlights an alternative approach: Delivering certain gut microbes to mice boosted antibody levels in mice, protecting them against the widespread inflammation that can lead to sepsis.
Sore throats should be treated with painkillers and not antibiotics, according to new guidelines produced by the National Institute for Health and Care Excellence and Public Health England. According to NICE, antibiotics are prescribed to treat sore throats in 60 percent of cases, but evidence shows that the majority of people will get better without them.
Scientists at the UNC School of Medicine have found that a bacterium can become much more or less susceptible to an antibiotic depending on the specific bacterial community in its midst.
First, it's important to remember why you’re on antibiotics to begin with: You feel awful and, with some help from your prescription, your body is working to fight off a nasty bacterial infection. (Antibiotics cannot treat anything viral, like a flu.)
In a recent study, researchers investigated whether there is a link between children’s antibiotics and the rise of autoimmune diseases such as type 1 diabetes and celiac disease.
Warp Drive Bio, Inc., a drug discovery company developing therapeutics that exploit the molecules and mechanisms of nature, announced today that it has formed a strategic collaboration with Roche to discover and develop multiple novel classes of antibiotics. The serious global health threat of multi-drug-resistant bacterial infections has created an urgent need for new antibiotics with novel structures and mechanisms of action.
(CNN)Too few new antibiotics are under development to combat the threat of multidrug-resistant infections, according to a new World Health Organization report published Tuesday. Adding to the concern: It is likely that the speed of increasing resistance will outpace the slow drug development process.
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.